Cvs Health Corporation · NYSE:CVS

Mandadi Tilak received 22,277 Cvs Health Corporation shares as an award (Form 4)

Traded Mar 31 to Apr 1, 2026 · Filed Apr 2, 2026

From Mar 31 to Apr 1, 2026, Mandadi Tilak (EVP, Chief Exp & Tech Officer) received 22,277 Cvs Health Corporation shares as an award at US$71.82 for US$1.6M, leaving 79,684 shares. Filed Apr 2, 2026 (Form 4).

Awarded
22,277 shares
Price
US$71.82
Value
US$1.6M
Holding after
79,684 shares
Trading plan
No
Role
EVP, Chief Exp & Tech Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Common Stock (RSUs)Award22,277US$71.8288,543Direct
Apr 1, 2026Common StockShares withheld for tax3,634US$72.4979,684Direct

Source

View original at SEC

Related